SPARC and neoplasm: The strong affinity between SPARC and albumin contributed to the enhanced utilization of nab-paclitaxel by tumor cells, thereby potentially augmenting the therapeutic efficacy (Pascual-Pasto et al. 2022; Tai and Tang 2008).